The results of a large international TRANSFORM II clinical trial in one year's time, with the use of a syrolyum coating balloon, show an equivalent result to drug-release stents.

Summary

The latest major clinical trial, published in TCT 2026, found that MagicTouch's permanent non-insert treatment strategy using a syrolyme coated balloon (SCB) was used to demonstrate the inequality of treatment with an evaryoma release stent for new coronary artery disease. Tampa, Florida, November 3, 2026 — Syrolimus-coated balloon, SCB is now being used as a treatment strategy...